TH68059A - Methods for treating severe heart failure And pharmaceuticals for that condition - Google Patents
Methods for treating severe heart failure And pharmaceuticals for that conditionInfo
- Publication number
- TH68059A TH68059A TH401000582A TH0401000582A TH68059A TH 68059 A TH68059 A TH 68059A TH 401000582 A TH401000582 A TH 401000582A TH 0401000582 A TH0401000582 A TH 0401000582A TH 68059 A TH68059 A TH 68059A
- Authority
- TH
- Thailand
- Prior art keywords
- heart failure
- halogen
- pharmaceutical
- small alkyl
- severe heart
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title claims abstract 6
- 239000003814 drug Substances 0.000 title claims abstract 5
- 238000000034 method Methods 0.000 title claims abstract 3
- 239000000126 substance Substances 0.000 claims abstract 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract 8
- 150000003839 salts Chemical class 0.000 claims abstract 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract 6
- 229910052736 halogen Inorganic materials 0.000 claims abstract 6
- 150000002367 halogens Chemical class 0.000 claims abstract 5
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 239000000470 constituent Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 230000001225 therapeutic effect Effects 0.000 claims abstract 2
- -1 2-methylbenzoyl amino Chemical group 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000005426 pharmaceutical component Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
Abstract
DC60 (18/05/47) วิธีสำหรับรักษาภาวะหัวใจล้มเหลวชนิดรุนแรง ซึ่งประกอบรวมด้วยการให้ปริมาณที่ให้ผล ของสารประกอบเบนซาเซพีน (1) (สูตรเคมี) (1) แก่ผู้ป่วย ซึ่ง R1 คือ H หรือแฮโลเจน, R2 คือ OH, หรือ -NR5R6(R5 และ R6 คือ H หรือแอลคิลขนาดเล็ก, R3 คือ H , แฮโลเจน, แอลคิลขนาดเล็ก, หรือแอลคอกซิขนาดเล็ก, R4 คือแฮโลเจน, แอลคิลขนาดเล็ก หรือแอลคอกซิขนาดเล็ก, หรือเกลือของสารเหล่า นั้น, และองค์ประกอบทางเภสัชกรรมที่มีสาร ประกอบเบนซาเซพีน (1) หรือเกลือของสารเหล่านั้น และการใช้สารประกอบ (1) หรือ เกลือของ สารเหล่านั้นสำหรับเตรียมเภสัชภัณฑ์สำหรับการรักษา ภาวะหัวใจล้มเหลวชนิดรุนแรง: สิทธิบัตรยา DC60 (18/05/47) A method for treating severe heart failure. Which consists of providing a productive quantity Of benzacepine (1) (chemical formula) (1) to patients where R1 is H or halogen, R2 is OH, or -NR5R6 (R5 and R6 are H or small alkyl, R3. Is H, the halogen, the small alkyl, or the small alkyl, R4 is the halogen, the small alkyl. Or small alkalis, or salts of those substances, and pharmaceutical constituents with substances Contains benzene (1) or salt of those substances. And the use of compounds (1) or their salts for the preparation of therapeutic pharmaceuticals. Severe Heart Failure: Drug Patents
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH68059A true TH68059A (en) | 2005-03-24 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2519660C2 (en) | Mode of dosing selective s1p1 receptor agonist | |
| JP2004531516A5 (en) | ||
| JP2005531557A (en) | Use of effective compounds as selective opiate receptor modulators | |
| JP2006501240A5 (en) | ||
| TWI255817B (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
| IN2015DN01132A (en) | ||
| RU2008133654A (en) | METHOD AND MEDICINE FOR TREATMENT OF SEVERE HEART FAILURE | |
| NO20065904L (en) | Therapeutic compounds | |
| MXPA05012810A (en) | Memantine oral dosage forms. | |
| AR045289A1 (en) | ORAL DOSAGE FORM OF CONTROLLED RELEASE THAT INCLUDES 4- (2-DI-N-PROPILAMINOETIL) - 2 (3H) -INDOLONE (ROPI-NIROL) AND USE OF SUCH DOSAGE FORM FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| JP6137833B2 (en) | Use of 4-aminopyridine to ameliorate neurocognitive and / or neuropsychiatric disorders in patients suffering from demyelinating and other nervous system diseases | |
| EA200601846A1 (en) | CONTAINING BENZOXASINS MEDICINAL COMBINATIONS FOR THE TREATMENT OF DISEASES OF RESPIRATORY TRACKS | |
| US11077118B2 (en) | Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake | |
| FI3749308T3 (en) | Treatment of patients with classic fabry disease with migalastat | |
| RU2008119454A (en) | MEDICINE FOR PROTECTION OF MOTOR NEURON IN PATIENTS WITH LATERAL AMYOTROPHIC SCLEROSIS | |
| JPS59501459A (en) | Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of use thereof | |
| RU2007119067A (en) | MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA | |
| CN101569626B (en) | method of treating movement disorders using barbituric acid derivatives | |
| TH68059A (en) | Methods for treating severe heart failure And pharmaceuticals for that condition | |
| ATE404192T1 (en) | USE OF NEFIRACETAM TO TREAT POSTISCHEMIC NEURODEGENERATION | |
| JP2004521140A5 (en) | ||
| CA2368352A1 (en) | Method for treating neurodegeneration | |
| RU2002113978A (en) | A method of stimulating motor activity of the intestine | |
| RU2414895C2 (en) | Method of treating liver affection in leprosy patients | |
| EP1940376B1 (en) | Use of neboglamine in the treatment of toxicodependency |